The France Foundation

Clearing the Air on Chuck’s Asthma

Overview / Abstract:	LEARNING OBJECTIVES Upon completion of the activity, participants should be able to: Perform a thorough assessment of asthma severity and control in day-to-day practice Explain how mechanisms of action of new/emerging type 2 inflammation-directed treatments address the underlying immunology of asthma Select appropriate type 2 inflammation-targeted therapies on the basis of safety and efficacy data, and phenotype
Expiration	Jun 30, 2020
Discipline(s)	Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physical Therapy CE, Physician CME, Physician Assistant CME, Radiology / RAD Tech CE, Respiratory Therapy CE
Format	Webinar / Webcast / Video
Credits / Hours	0.25
Accreditation	ACCME
Presenters / Authors / Faculty	James Donohue, MD Professor of Medicine Pulmonary Disease and Critical Care Medicine UNC School of Medicine Chapel Hill, NC
Sponsors / Supporters / Grant Providers	This activity is supported by independent educational grants from Actelion Pharmaceuticals US, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Genentech and Mallinckrodt Pharmaceuticals.
Keywords / Search Terms	The France Foundation, Asthma, Free CE, CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map